Go to the Globe and Mail homepage

Jump to main navigationJump to main content

File photo of a doctor holding stethoscope. (Oleg Prikhodko/iStockphoto)
File photo of a doctor holding stethoscope. (Oleg Prikhodko/iStockphoto)

Baxter in talks to buy Gambro for $4-billion: report Add to ...

Baxter International Inc is in talks to buy Swedish medical-equipment maker Gambro AB for about $4-billion (U.S.) to boost its kidney dialysis business, The Wall Street Journal reported on Friday.

Citing people familiar with the matter, the newspaper said the companies are trying to complete the deal within the next two to three weeks.

More Related to this Story

Baxter, based in suburban Chicago, also manufactures drug infusion pumps and blood therapy products. The company could not be reached by Reuters for comment.

Gambro declined comment, the Journal said.

Gambro is owned by two Nordic private-equity firms. Investor AB, which owns 49 per cent, declined to comment; EQT, which owns 51 per cent, was not immediately available.

Baxter’s dialysis machines perform a form of dialysis called peritoneal, which can be performed at home. Gambro is one of the largest makers of equipment for hemodialysis, which is generally performed in a hospital or clinic.

Baxter has considered a deal with Gambro for years, according to The Wall Street Journal reported, quoting one person who is familiar with the companies.

 
Live Discussion of BAX on StockTwits
More Discussion on BAX-N

Topics:

In the know

Most popular video »

Highlights

More from The Globe and Mail

Most Popular Stories